If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

Share Price is delayed by 15 minutes
Get Live Data
80.10    -0.68 (-0.84%)
Bid:
80.00
Ask:
80.06
Spread: 0.06 (0.075%)
Market Cap: £2.78b
TW. Live PriceLast checked at - London Stock Exchange

Intraday Taylor Wimpey Share Chart

Trading Statement

23 Apr 2024 07:00

RNS Number : 5884L
Taylor Wimpey PLC
23 April 2024
Β 

23 April 2024

Taylor Wimpey plc

Trading statement for the period covering 1 January 2024 to today

Β 

Spring selling season progressing as expected, full year 2024 guidance reiterated

Taylor Wimpey plc is holding its Annual General Meeting (AGM) today at 10:30am at the Crowne Plaza Hotel in Gerrards Cross, where the following comments will be made regarding current trading, financial performance, and outlook for the financial year.

Jennie Daly, Chief Executive commented:

"We have made a good start to 2024 with the Spring selling season progressing as expected. While we are mindful of ongoing market uncertainty and affordability challenges, it is pleasing to see continued market stability supported by good mortgage availability and sustained customer confidence. Our teams are working hard on the ground to support our customers through the buying process, underpinned by our strong marketing strategy and the quality and location of our homes, which are driving good levels of interest.

Looking ahead, we are confident that we have a strong and resilient business supported by a high-quality, well-located landbank. We remain focused on driving value and investing in the long term sustainability of the business, and we remain on track to deliver our guidance for 2024 while ensuring we are positioned for growth from 2025, assuming supportive market conditions."

UK current trading

The Spring selling season is progressing in line with our expectations. Traffic to our website is encouraging and there are good levels of visitors to our sites despite some market uncertainty and affordability challenges for some customers. Lenders continue to be supportive and mortgage rates remain competitive and below last year's highs, with good product availability.

Our net private sales rate for the year to 21 April 2024 was 0.73 per outlet per week (2023: 0.75), with a cancellation rate of 13% (2023: 15%). Excluding bulk sales, our net private sales rate for the year to 21 April 2024 was 0.69 per outlet per week (2023: 0.66).

As at 21 April 2024, our total order book value stood at Β£2,090 million (2023: Β£2,379 million) representing 7,686 homes (2023: 8,576 homes).

High-quality landbank

We are differentiated by our high-quality, well-located landbank, which is supported by a strong strategic land pipeline, providing additional optionality through the cycle. We continue to focus on the conversion of plots from our strategic pipeline and successfully converted c.1.5k plots into our short term landbank in the period. We remain selective in our approach to new acquisitions but will be active where we see opportunities that balance risk, reward and returns to create shareholder value. In the year to date we have approved c.1.4k new plots. At the end of March 2024, our short term landbank stood at c.81k plots (2023: c.86k plots), with a further c.140k potential plots (2023: c.140k plots) in our strategic pipeline.

Dividend

As previously announced, we intend to pay a 2023 final ordinary dividend of 4.79 pence per share on 10 May 2024 (2022 final dividend: 4.78 pence per share), subject to shareholder approval at today's AGM. This is in line with our Ordinary Dividend Policy to return c.7.5% of net assets annually, in two equal instalments.

Outlook

We remain focused on prioritising value over volume, building a strong order book and positioning ourselves for growth from 2025, assuming supportive market conditions.

We continue to expect 2024 UK completions (excluding JVs) to be in the range of 9,500 to 10,000, with completions weighted 45% / 55% in favour of the second half of the year. As previously guided, first half operating profit margin* will reflect slightly lower pricing in the order book and build cost inflation embedded in work in progress of around 4%.

Looking ahead, we remain well positioned in an attractive market with significant unmet demand. Our strong landbank and clear strategy enable us to build high-quality homes, create thriving communities and drive value for our stakeholders through the cycle and into the long term.

Β 

* Operating profit is defined as profit on ordinary activities before financing, exceptional items and tax, after share of results of joint ventures. Operating profit margin is defined as operating profit divided by revenue.

Β 

Note:

2023 relates to the equivalent trading period, unless stated

Β 

-Ends-

Β 

CEO Jennie Daly and Group Finance Director Chris Carney will be hosting a conference call with Q&A for analysts and investors at 8:30am on 23 April 2024. The call will be recorded and streamed live to our website: www.taylorwimpey.co.uk/corporate/investors/results-and-reports

Β 

For further information please contact:

Taylor Wimpey plc Tel: +44 (0) 1494 885656

Β 

Jennie Daly, CEO

Chris Carney, Group Finance Director

Debbie Archibald, Investor Relations

Andrew McGeary, Investor Relations

Β 

FGS Global TaylorWimpey@fgsglobal.com

Faeth Birch

Anjali Unnikrishnan

James Gray

Notes to editors:

Β 

Taylor Wimpey plc is a customer-focused homebuilder operating at a local level from 22 regional businesses across the UK. We also have operations in Spain. Our purpose is to deliver great homes and create thriving communities.

Β 

For further information, please visit the Group's website: www.taylorwimpey.co.uk/corporate

Β 

Follow our company page on LinkedIn, Taylor Wimpey plc

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTFLFIASFIFFIS
Date   Source Headline
29th Jul 20207:00 amRNSHalf year results for the period end 28 June 2020
9th Jul 202011:54 amRNSDirector/PDMR Shareholding
1st Jul 202011:23 amRNSTotal Voting Rights
23rd Jun 20202:16 pmRNSHolding(s) in Company
22nd Jun 20204:19 pmRNSDirector/PDMR Shareholding
19th Jun 20203:32 pmRNSHolding(s) in Company
18th Jun 20205:30 pmRNSTaylor Wimpey
18th Jun 20207:01 amRNSResults of the Placing
17th Jun 20204:38 pmRNSProposed placing of Ordinary Shares
17th Jun 20204:37 pmRNSRetail Offer via PrimaryBid.com
15th Jun 20207:29 amRNSDirector Declaration
9th Jun 20204:28 pmRNSDirector/PDMR Shareholding
5th Jun 20207:00 amRNSChange of Auditor
5th Jun 20207:00 amRNSBusiness update
1st Jun 20203:00 pmRNSTotal Voting Rights
14th May 20207:00 amRNSDirector Declaration
13th May 20207:00 amRNSPhased reopening of sales centres and show homes
12th May 20203:33 pmRNSDirector/PDMR Shareholding
1st May 20202:35 pmRNSTotal Voting Rights
1st May 20207:00 amRNSDirector Declaration
27th Apr 20207:00 amRNSDisclosure of rights attached to equity shares
23rd Apr 20201:06 pmRNSResult of AGM
23rd Apr 20207:00 amRNSTrading Statement
9th Apr 20202:29 pmRNSDirector/PDMR Shareholding
1st Apr 202012:17 pmRNSTotal Voting Rights
1st Apr 20207:00 amRNSCOVID-19 - Remuneration update
26th Mar 20207:08 amRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSDirectorate Change
24th Mar 202010:10 amRNSNotice of AGM
16th Mar 20203:28 pmRNSAnnual Financial Report
10th Mar 202012:24 pmRNSDirector/PDMR Shareholding
5th Mar 20208:47 amRNSDirector/PDMR Shareholding
2nd Mar 20204:03 pmRNSTotal Voting Rights
28th Feb 202010:56 amRNSDirectorate Change
27th Feb 202012:19 pmRNSDirector/PDMR Shareholding
26th Feb 20204:24 pmRNSDirector/PDMR Shareholding
26th Feb 20207:00 amRNSTaylor Wimpey plc - Full year results
24th Feb 20204:26 pmRNSBoard and Committee changes
11th Feb 20204:09 pmRNSDirector/PDMR Shareholding
3rd Feb 202012:41 pmRNSTotal Voting Rights
3rd Feb 202010:13 amRNSDirectorate Change
14th Jan 20207:00 amRNSTrading Statement
9th Jan 20203:45 pmRNSDirector/PDMR Shareholding
2nd Jan 20202:01 pmRNSBlock listing Interim Review
2nd Jan 20202:00 pmRNSBlock listing Interim Review
2nd Jan 202010:17 amRNSTotal Voting Rights
10th Dec 20192:14 pmRNSDirector/PDMR Shareholding
3rd Dec 20194:28 pmRNSDirector/PDMR Shareholding
2nd Dec 20194:06 pmRNSDirector/PDMR Shareholding
2nd Dec 201911:54 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.